Gengos Andrew's Form 4 filing
LeonaBio, Inc. (LONA) · filed Sep 5, 2024
- Accession no.
- 0001415889-24-022987
- Filed
- Sep 5, 2024
- Trade date
- May 20-Sep 5, 2024
- Filing delay
- 108 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $725.04. It was filed 108 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gengos AndrewCIK 0001563623 | Officer (CFO and Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Common Stock | AGrant or awardAcquired | +10,000 | $1.34 | +$13,400 | 93,804 | Direct | |
| Sep 3, 2024 | Common Stock | AGrant or awardAcquired | +5,000 | $0.00 | $0 | 98,804 | Direct | |
| Sep 5, 2024 | Common Stock | SSaleDisposed | −1,272 | $0.57 | −$725.04 | 97,532 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.